- Advertisement -
ISLAMABAD, Nov 14 (APP):Special Assistant to the Prime Minister on Industries and Production Haroon Akhtar Khan on Friday reaffirmed the government’s commitment to strengthening small businesses through targeted reforms and policies.
The SAPM held a meeting with the Small and Medium Enterprises (SMEs) Cluster of Rawalpindi, where pharmaceutical SMEs briefed him on their challenges and operational constraints, said a news release.
Haroon assured participants that the government is fully committed to addressing their concerns in line with the vision of prime minister.
The meeting was attended by the President Rawalpindi Chamber of Commerce and Industry Usman Shoukat, Acting CEO of SMEDA Nadia J. Seth, and representatives from the Ministry of Industries and Production.
Haroon said that the prime minister’s priority is to align SMEs with modern technology, strengthen their role in the economy, and enhance their contribution to employment generation and exports.
“SMEs are the backbone of the economy, and their role is commendable. The government is committed to empowering them through targeted reforms and support policies.” he added.
The SAPM announced that the government is formulating a policy to provide Pharma Parks for pharmaceutical SMEs. A model of a Pharma Park is being developed and will soon be presented to the Prime Minister.
He added that the government, in collaboration with the banking sector, is working to improve SMEs’ access to credit, while SMEs participating in the export sector will be provided export financing to boost their international competitiveness.
Haroon Akhtar reiterated the government’s commitment to elevating the quality and standards of Pakistani SMEs to meet global requirements. He emphasized that commercial attachés and diplomats must play a more proactive role in supporting SMEs and identifying export opportunities.
The SAPM also underlined the PM’s vision to promote local vaccine manufacturing in Pakistan, noting that the National Vaccine Policy is currently in the final stages of development. He stated that enhancing domestic vaccine production will strengthen health security and simultaneously benefit the SME sector.